SubsidieMeestersAn AI powered turn-key solution for MRI based interventional cardiology
Nano4Imaging aims to deliver TRACKR, a B2B platform enhancing MRI-guided interventional radiology with nano-coatings and real-time tracking software for commercial device makers.
Projectdetails
Introduction
Nano4Imaging (N4I) is a med-tech company specialized in MR based interventional radiology. We have previously successfully commercialized EmeryGlide, a MR compatible guidewire in paediatric cardiology.
Project Overview
In this project, we will deliver TRACKR – a ‘turn-key’ platform that provides the currently missing enabling technologies for MRI guided interventional radiology.
TRACKR Technology Components
The TRACKR technology consists of:
-
A NANO-COATING PLATFORM based on proprietary MagnaFy technology. The nano-coatings can be applied on any commercial intervention device (catheter, guide-wire, balloon) and increase MR visibility drastically.
-
A REAL-TIME TRACKING SOFTWARE based on novel deep learning algorithms that allows real-time tracking of the MagnaFy coated devices during an interventional procedure.
Commercialization Strategy
The platform will be commercialized as a B2B service to interventional device makers. Four large players (Terumo, B.Braun, COOK, Numed) are ongoing collaborators and will be the early adopters.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.482.709 |
| Totale projectbegroting | € 3.546.727 |
Tijdlijn
| Startdatum | 1-4-2023 |
| Einddatum | 31-12-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- NANO4IMAGING GMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
AI-based clinical software for fully automated Cardiac Magnetic Resonance reportingAI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes. | EIC Accelerator | € 1.753.842 | 2022 | Details |
Accessible MRIThe AMRI project by CHIPIRON aims to develop an affordable, compact MRI scanner using ultra-low magnetic fields to enhance accessibility and diagnostic capabilities in underserved regions. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Foundation Model-Based Biomarker Platform for Radiology and Clinical TrialsFoundRa aims to revolutionize radiology with an AI platform that accelerates precision medicine by generating scalable biomarkers and supporting radiologists in clinical trials and diagnostics. | EIC Accelerator | € 2.499.875 | 2024 | Details |
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgeryThericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024. | EIC Accelerator | € 2.500.000 | 2022 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting
AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.
Accessible MRI
The AMRI project by CHIPIRON aims to develop an affordable, compact MRI scanner using ultra-low magnetic fields to enhance accessibility and diagnostic capabilities in underserved regions.
Foundation Model-Based Biomarker Platform for Radiology and Clinical Trials
FoundRa aims to revolutionize radiology with an AI platform that accelerates precision medicine by generating scalable biomarkers and supporting radiologists in clinical trials and diagnostics.
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgery
Thericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Nano-Biological Contrast Agent Platform for MRI ImagingNANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency. | ERC Proof of... | € 150.000 | 2022 | Details |
SaorTrack: Wireless Position Tracking in the ORThis project aims to develop a wireless magnetic tracking system to enhance accuracy in electrophysiology mapping and enable precise localization in capsule endoscopy, improving clinical workflows and diagnostics. | ERC Proof of... | € 150.000 | 2024 | Details |
RESTORING IMMUNITY CONTROL OF GI CANCERSTIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization. | EIC Transition | € 2.007.750 | 2025 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platformThe NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology. | EIC Transition | € 2.489.162 | 2023 | Details |
Nano-Biological Contrast Agent Platform for MRI Imaging
NANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency.
SaorTrack: Wireless Position Tracking in the OR
This project aims to develop a wireless magnetic tracking system to enhance accuracy in electrophysiology mapping and enable precise localization in capsule endoscopy, improving clinical workflows and diagnostics.
RESTORING IMMUNITY CONTROL OF GI CANCERS
TIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization.
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platform
The NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology.